Pakistan’s response reflects the tightrope its leadership now faces as it attempts to maintain ties with Iran while also trying not to alienate Washington.

Hegseth avoided giving a clear timeline for how long the military campaign against Iran could last, saying the decision ultimately rests with Trump.

Great. Good morning, everyone. Thanks for joining us here at day 2 of the Leerink Partners Global Healthcare Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at Leerink.

Good day, and thank you for standing by. Welcome to the Ultralife Corporation Fourth Quarter 2025 Results Call. [Operator Instructions] Please be advised that today's conference is being recorded. I'd ...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A ...

Fourth quarter revenue of $32.9 million, up 26% q/q, 148.9% y/y, in line with target guidance; Gross margin improvement of approximately 1,500 basis points q/q and 4,900 points y/ ...

Retail investors have a few ways to reduce risk in a stock portfolio. If you want to hedge an equity position, you could add ...

The US is entering a new chapter in nuclear energy, driven by a simple reality: The shifting fundamentals of power demand have made it a necessity. Data centers, advanced manufacturing, ...

WILMINGTON, DE – March 09, 2026 – PRESSADVANTAGE – ...